Clinical Trial Update: A Study to Investigate Safety and Efficacy of iGlarLixi in Adult Patients With Type 2 Diabetes Mellitus [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update describing a study to evaluate the safety and efficacy of iGlarLixi in adults with Type 2 diabetes mellitus; the study is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• iGlarLixi (insulin glargine + lixisenatide)

Snippet

Sponsor: Sanofi | Conditions: Type 2 Diabetes | Phase 4 | Status: ACTIVE_NOT_RECRUITING